drug
rasagiline mesylate
Marketedupdated 5mo agoby Carnegie Pharmaceuticals LLC
Approvedcommunity read0 votes
indications
investigational
Parkinson's Disease
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 5, 2026
58 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Aug 27, 2027compositionUS 7815942323d
- Aug 27, 2027compositionUS 7815942323d
- Dec 5, 2026formulationUS 757283458d
- Dec 5, 2026formulationUS 757283458d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that